This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Radio-active iodine and risk of cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Franklyn et al (1) have undertaken a population-based cohort study examining the incidence and mortality of cancer following radioiodine treatment. Findings included:
    • a significant decrease in the total number of cancer diagnoses and deaths from cancer in the radioiodine group compared to matched data from the general population (1)
    • a significant, but small, increase in the incidence of small bowel and thyroid cancers - however the absolute risk of these cancers remained low

Reference:

  • (1) Franklyn JA, Maisonneuve P, Sheppard MC et al (1999). Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet, 338 (11), 712-718.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.